openPR Logo
Press release

Growth in the Compounding Pharmacy Market Driven by Personalized Medicine Trends

12-13-2024 09:02 AM CET | Health & Medicine

Press release from: Mordor Intelligence

compounding pharmacy market

compounding pharmacy market

Mordor Intelligence has published a new report on the Compounding Pharmacy Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The compounding pharmacy market is projected to be valued at USD 14.31 billion in 2024 and is anticipated to grow to USD 18.86 billion by 2029, registering a CAGR of 5.68% throughout the forecast period (2024-2029). The market's growth is driven by the increasing demand for personalized medicine, which tailors treatment to the unique characteristics of individual patients.

Report Overview - https://www.mordorintelligence.com/industry-reports/compounding-pharmacy-market

Key Trends Driving the Compounding Pharmacy Market

Rising Demand for Personalized Medicine

The shift towards precision medicine is one of the primary trends fueling the growth of compounding pharmacies. Custom-compounded medications allow healthcare providers to cater to individual patient needs, addressing unique requirements such as dosage forms, allergy-friendly formulations, or specific strength preferences.

Increasing Prevalence of Chronic Diseases

Chronic conditions like diabetes, arthritis, and cardiovascular diseases necessitate tailored therapeutic approaches. Compounding pharmacies are gaining traction for their ability to provide specialized medications that are not commercially available, improving adherence and treatment outcomes.

Advancements in Compounding Technology

Technological advancements, including automated systems and sterile compounding environments, are enhancing the safety, accuracy, and efficiency of compounded medications. These developments are reducing risks associated with contamination and dosing errors, increasing trust in compounded solutions.

Evolving Regulatory Landscape

Regulatory agencies like the FDA are focusing on ensuring safety and quality in compounding practices. Stricter guidelines and oversight mechanisms are driving improvements in production standards and fostering confidence among healthcare providers and patients.

Market Segmentation: Detailed Insights

The Compounding Pharmacy Market is segmented by Product, Therapeutic Area, and End-User:

By Product:

Oral Medications: Tablets, capsules, and suspensions tailored to patient needs.

Topical Medications: Creams, ointments, and gels formulated for skin application.

Suppositories: Specialized formulations for rectal or vaginal use.

Injectables: Custom doses for precise medical requirements.

Others: Including ophthalmic and nasal preparations.

By Therapeutic Area:

Pain Management: Customized solutions for chronic and acute pain relief.

Hormone Replacement Therapy (HRT): Formulations addressing specific hormonal imbalances.

Dermatology: Treatments for skin conditions such as eczema and psoriasis.

Others: Covering a range of conditions, including infectious diseases and oncology.

By End-User:

Hospitals and Clinics: Bulk compounding for patient treatments.

Retail Pharmacies: Individualized prescriptions for walk-in customers.

Home Healthcare: Personalized medications for remote patient care.

This segmentation underscores the market's versatility, catering to diverse medical needs and healthcare settings.

Get a Customized Report Tailored to Your Requirements:- https://www.mordorintelligence.com/market-analysis/alternative-medicine

Key Players: Shaping the Future of Compounding Pharmacy

Leading companies in the Compounding Pharmacy Market are driving innovation, ensuring compliance with regulations, and expanding their offerings to meet growing demand. Key players include:

Fagron NV: A global leader in pharmaceutical compounding with a focus on innovation and quality.

B. Braun Medical Inc.: Known for sterile compounding and injectable solutions.

PharMEDium Services LLC: Specializes in customized sterile preparations for hospitals and clinics.

Advanced Pharma: Provides a wide range of compounded medications with a focus on pain management.

Athenex Inc.: Innovates in oncology compounding and other specialty areas.

These companies are investing heavily in R&D, partnerships, and compliance to maintain a competitive edge.

Conclusion: A Promising Future for Compounding Pharmacy

The Compounding Pharmacy Market is set to experience robust growth, driven by increasing demand for personalized medicine and advanced therapeutic solutions. Innovations in compounding technology, along with stringent regulatory frameworks, are shaping a more efficient and reliable market landscape. As chronic diseases and patient-specific needs rise, compounded medications will play a critical role in improving healthcare outcomes globally.

Industry Related Reports

Pharmaceutical Isolator Market: The report provides a comprehensive analysis and valuation of the Global Pharmaceutical Isolators Market. The market is segmented based on Type (Closed Isolator Systems and Open Isolator Systems), Application (Aseptic Isolators, Containment Isolators, and Other Applications), End-user (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Other End-users), and Geography, which includes regions such as North America, Europe, Asia-Pacific, the Middle East, Africa, and South America.

To know more visit this link: https://www.mordorintelligence.com/industry-reports/pharmaceutical-isolator-market

polybutylene terephthalate pbt market: The Polybutylene Terephthalate (PBT) Market is categorized by End-User Industry (Automotive, Electrical and Electronics, Industrial and Machinery) and by Region (Africa, Asia-Pacific, Europe, Middle East, North America, and South America). The market is analyzed in terms of both Value (USD) and Volume (tons). Key data points include automobile production volumes, new construction floor area, plastic packaging production volumes, plastic resin production, imports and exports, and plastic resin prices.

To know more visit this link: https://www.mordorintelligence.com/industry-reports/polybutylene-terephthalate-pbt-market

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growth in the Compounding Pharmacy Market Driven by Personalized Medicine Trends here

News-ID: 3786520 • Views:

More Releases for Compounding

NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global
Compounding Pharmacies Market 2020: Top Key Players Are Triangle Compounding Pha …
Industry Overview: Updated research report on Compounding Pharmacies Market by ‘Market Growth Insight’ delivers pivotal information on the market including drivers, restraints, challenges, and opportunities. The Compounding Pharmacies report is useful to business owners, manufacturers, distributors, suppliers, marketing personnel, strategists, and customers since it helps them to understand the current market scenario and make future planning, while considering the risks that are also mentioned in the report. The Compounding Pharmacies report
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc. Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured